# PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients

> **NCT05704166** · PHASE2 · RECRUITING · sponsor: **Fujian Medical University Union Hospital** · enrollment: 214 (estimated)

## Conditions studied

- Acute Lung Injury
- Prevention

## Interventions

- **DRUG:** Pirfenidone/Placebo

## Key facts

- **NCT ID:** NCT05704166
- **Lead sponsor:** Fujian Medical University Union Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-03-16
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 214 (ESTIMATED)
- **Last updated:** 2025-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05704166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05704166, "PirfenidoneVsPlacebo as Prophylaxis Against Acute Radiation-induced Lung Injury Following HFRT in Breast Cancer Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05704166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*